What is the trade name of fondaparinux?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Trade Name for Fondaparinux

Fondaparinux is marketed under the trade name Arixtra. 1

Key Product Information

  • Generic name: Fondaparinux sodium 2, 3
  • Brand name: Arixtra 1, 2
  • Manufacturer: Sanofi-Synthelabo (now part of Sanofi) 4
  • Drug class: Synthetic pentasaccharide, selective factor Xa inhibitor 1, 2, 4

Clinical Context

Arixtra (fondaparinux) is FDA-approved for:

  • Prophylaxis of venous thromboembolism (VTE) following major orthopedic surgery 1, 2
  • Treatment of acute deep vein thrombosis and pulmonary embolism 1, 5
  • Treatment of acute coronary syndromes (in combination with other therapies) 1

The medication is administered as a once-daily subcutaneous injection due to its 17-21 hour half-life, which distinguishes it from low-molecular-weight heparins that often require twice-daily dosing. 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Fondaparinux: a Factor Xa inhibitor for antithrombotic therapy.

Expert opinion on pharmacotherapy, 2004

Research

Fondaparinux, the first selective factor Xa inhibitor.

Current opinion in hematology, 2003

Research

Fondaparinux: an update on new study results.

European journal of clinical investigation, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.